Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells

Chemistry and Biology

Volumn 11, Issue 8, 2004, Pages 1165-1175

  Chiu, Ya Lin ^a   Ali, Akbar ^a   Chu, Chia Ying ^a   Cao, Hong ^a   Rana, Tariq M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMER; CARBAMIC ACID DERIVATIVE; CDK9 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 9; NANOMATERIAL; PEPTIDE FRAGMENT; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL SURVIVAL; CHEMISTRY; CYTOPLASM; GENETICS; HELA CELL; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; RNA TRANSPORT;

BASE SEQUENCE; BIOPOLYMERS; CARBAMATES; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 9; CYTOPLASM; GENE PRODUCTS, TAT; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NANOSTRUCTURES; PEPTIDE FRAGMENTS; RNA INTERFERENCE; RNA TRANSPORT; RNA, SMALL INTERFERING;

EID: 4344651353     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.06.006     Document Type: Article

References (52)

1. Hammond S.M., Caudy A.A., Hannon G.J. Post-transcriptional gene silencing by double-stranded RNA. Nat. Rev. Genet. 2:2001;110-119
2. McManus M.T., Sharp P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3:2002;737-747
3. Hammond S.M., Bernstein E., Beach D., Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature. 404:2000;293-296
4. Nykanen A., Haley B., Zamore P.D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell. 107:2001;309-321
5. Chiu Y.L., Rana T.M. RNAi in human cells basic structural and functional features of small interfering RNA. Mol. Cell. 10:2002;549-561
6. Elbashir S.M., Martinez J., Patkaniowska A., Lendeckel W., Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20:2001;6877-6888
7. Hutvagner G., Zamore P.D. A MicroRNA in a multiple-turnover RNAi enzyme complex. Science. 297:2002;2056-2060
8. Shi Y. Mammalian RNAi for the masses. Trends Genet. 19:2003;9-12
9. Paddison P.J., Caudy A.A., Hannon G.J. Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. Acad. Sci. USA. 99:2002;1443-1448
10. Paul C.P., Good P.D., Winer I., Engelke D.R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20:2002;505-508
11. Lee N.S., Dohjima T., Bauer G., Li H., Li M.J., Ehsani A., Salvaterra P., Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20:2002;500-505
12. Miyagishi M., Taira K. U6 promoter driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20:2002;497-500
13. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553
14. Qin X.F., An D.S., Chen I.S., Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA. 100:2003;183-188
15. Shen C., Buck A.K., Liu X., Winkler M., Reske S.N. Gene silencing by adenovirus-delivered siRNA. FEBS Lett. 539:2003;111-114
16. Stewart S.A., Dykxhoorn D.M., Palliser D., Mizuno H., Yu E.Y., An D.S., Sabatini D.M., Chen I.S., Hahn W.C., Sharp P.A., et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA. 9:2003;493-501
17. Ohki E.C., Tilkins M.L., Ciccarone V.C., Price P.J. Improving the transfection efficiency of post-mitotic neurons. J. Neurosci. Methods. 112:2001;95-99
18. Lindgren M., Hallbrink M., Prochiantz A., Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 21:2000;99-103
19. Schwarze S.R., Dowdy S.F. In vivo protein transduction intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21:2000;45-48
20. Prochiantz A. Messenger proteins homeoproteins, TAT and others. Curr. Opin. Cell Biol. 12:2000;400-406
21. Luo D., Saltzman W.M. Synthetic DNA delivery systems. Nat. Biotechnol. 18:2000;33-37
22. Morris M.C., Chaloin L., Heitz F., Divita G. Translocating peptides and proteins and their use for gene delivery. Curr. Opin. Biotechnol. 11:2000;461-466
23. Ford K.G., Souberbielle B.E., Darling D., Farzaneh F. Protein transduction an alternative to genetic intervention? Gene Ther. 8:2001;1-4
24. Green M., Loewenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell. 55:1988;1179-1188
25. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 55:1988;1189-1193
26. Mann D.A., Frankel A.D. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10:1991;1733-1739
27. Vives E., Richard J.P., Rispal C., Lebleu B. TAT peptide internalization seeking the mechanism of entry. Curr. Protein Pept. Sci. 4:2003;125-132
28. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA. 91:1994;664-668
29. Vives E., Brodin P., Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:1997;16010-16017
30. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction delivery of a biologically active protein into the mouse. Science. 285:1999;1569-1572
31. Silhol M., Tyagi M., Giacca M., Lebleu B., Vives E. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur. J. Biochem. 269:2002;494-501
32. Console S., Marty C., Garcia-Echeverria C., Schwendener R., Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278:2003;35109-35114
33. Ignatovich I.A., Dizhe E.B., Pavlotskaya A.V., Akifiev B.N., Burov S.V., Orlov S.V., Perevozchikov A.P. Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J. Biol. Chem. 278:2003;42625-42636
34. Fittipaldi A., Ferrari A., Zoppe M., Arcangeli C., Pellegrini V., Beltram F., Giacca M. Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J. Biol. Chem. 278:2003;34141-34149
35. Potocky T.B., Menon A.K., Gellman S.H. Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 278:2003;50188-50194
36. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278:2003;585-590
37. Lebleu B. Delivering information-rich drugs - prospects and challenges. Trends Biotechnol. 14:1996;109-110
38. Moulton H.M., Hase M.C., Smith K.M., Iversen P.L. HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers. Antisense Nucleic Acid Drug Dev. 13:2003;31-43
39. Nakanishi M., Eguchi A., Akuta T., Nagoshi E., Fujita S., Okabe J., Senda T., Hasegawa M. Basic peptides as functional components of non-viral gene transfer vehicles. Curr. Protein Pept. Sci. 4:2003;133-139
40. Wadia J.S., Dowdy S.F. Modulation of cellular function by TAT mediated transduction of full length proteins. Curr. Protein Pept. Sci. 4:2003;97-104
41. Rudolph C., Plank C., Lausier J., Schillinger U., Muller R.H., Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J. Biol. Chem. 278:2003;11411-11418
42. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., D'Souza G.G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. USA. 100:2003;1972-1977
43. Torchilin V.P., Levchenko T.S. TAT-liposomes a novel intracellular drug carrier. Curr. Protein Pept. Sci. 4:2003;133-140
44. Nagahara H., Vocero-Akbani A.M., Snyder E.L., Ho A., Latham D.G., Lissy N.A., Becker-Hapak M., Ezhevsky S.A., Dowdy S.F. Transduction of full-length TAT fusion proteins into mammalian cells TAT-p27Kip1 induces cell migration. Nat. Med. 4:1998;1449-1452
45. Chiu Y.L., Rana T.M. siRNA function in RNAi a chemical modification analysis. RNA. 9:2003;1034-1047
46. Chiu Y.L., Cao H., Jacque J.M., Stevenson M., Rana T.M. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). J. Virol. 78:2004;2517-2529
47. Cho C.Y., Moran E.J., Cherry S.R., Stephans J.C., Fodor S.P., Adams C.L., Sundaram A., Jacobs J.W., Schultz P.G. An unnatural biopolymer. Science. 261:1993;1303-1305
48. Wang X., Huq I., Rana T.M. HIV-1 TAR RNA recognition by an unnatural biopolymer. J. Am. Chem. Soc. 119:1997;6444-6445
49. Klajnert B., Bryszewska M. Dendrimers properties and applications. Acta Biochim. Pol. 47:2001;199-208
50. Kawasaki H., Taira K. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 31:2003;700-707
51. Billy E., Brondani V., Zhang H., Muller U., Filipowicz W. Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc. Natl. Acad. Sci. USA. 98:2001;14428-14433
52. Zeng Y., Cullen B.R. RNA interference in human cells is restricted to the cytoplasm. RNA. 8:2002;855-860